Unknown

Dataset Information

0

Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B.

ABSTRACT: 3,5-Diaryl-4,5-dihydroisoxazoles were synthesized and evaluated as monoamine oxidase (MAO) enzyme inhibitors and iron chelators. All compounds exhibited selective inhibitory activity towards the B isoform of MAO in the nanomolar concentration range. The best performing compound was preliminarily evaluated for its ability to bind iron II and III cations, indicating that neither iron II nor iron III is coordinated. The best compounds racemic mixtures were separated and single enantiomers inhibitory activity evaluated. Furthermore, none of the synthesised compounds exhibited activity towards MAO A. Overall, these data support our hypothesis that 3,5-diaryl-4,5-dihydroisoxazoles are promising scaffolds for the design of neuroprotective agents.

SUBMITTER: Meleddu R 

PROVIDER: S-EPMC6009968 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B.

Meleddu Rita R   Distinto Simona S   Cirilli Roberto R   Alcaro Stefano S   Yanez Matilde M   Sanna Maria Luisa ML   Corona Angela A   Melis Claudia C   Bianco Giulia G   Matyus Peter P   Cottiglia Filippo F   Maccioni Elias E  

Journal of enzyme inhibition and medicinal chemistry 20171201 1

3,5-Diaryl-4,5-dihydroisoxazoles were synthesized and evaluated as monoamine oxidase (MAO) enzyme inhibitors and iron chelators. All compounds exhibited selective inhibitory activity towards the B isoform of MAO in the nanomolar concentration range. The best performing compound was preliminarily evaluated for its ability to bind iron II and III cations, indicating that neither iron II nor iron III is coordinated. The best compounds racemic mixtures were separated and single enantiomers inhibitor  ...[more]

Similar Datasets

Unknown Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A.
| S-EPMC6071705 | biostudies-literature
Unknown Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions.
| S-EPMC8623647 | biostudies-literature
Unknown Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
| S-EPMC7288026 | biostudies-literature
Unknown Amphetamine Derivatives as Monoamine Oxidase Inhibitors.
| S-EPMC6989591 | biostudies-literature
Unknown 3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.
| S-EPMC4286191 | biostudies-literature
Unknown Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.
| S-EPMC6864482 | biostudies-literature
Unknown Novel 1-(2-pyrimidin-2-yl)piperazine derivatives as selective monoamine oxidase (MAO)-A inhibitors.
| S-EPMC6009961 | biostudies-literature
Unknown Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
| S-EPMC8198649 | biostudies-literature
Unknown Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.
| S-EPMC4772270 | biostudies-literature
Unknown Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing.
| S-EPMC3241339 | biostudies-literature